![Douglas Kerr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Kerr
Chief Tech/Sci/R&D Officer at
DYNE THERAPEUTICS, INC.
Net worth: 4 M $ as of 2026-07-30
Profile
Douglas Kerr is currently Director at Cure Sma, Advisor at Atlas Venture Advisors, Inc., Science Advisor at Exceptional Ventures LLP since 2022, and Chief Medical Officer at Dyne Therapeutics, Inc. since 2024.
Former roles include Senior Director-Strategy & Portfolio Management at Biogen, Inc. from 2013 to 2015, Director at BlueRock Therapeutics LP, AAVantgarde Bio Srl, GenrAb, Inc., and Trace Neuroscience, Inc., Director at Faze Medicines, Inc. from 2021 to 2023, Vice President-Neurology at Shire Plc from 2015 to 2017, Associate Professor at The Johns Hopkins University School of Medicine from 1999 to 2010, Scientific Advisory Board Member at Disarm Therapeutics, Inc. from 2018 to 2021, Chief Medical Officer at Generation Bio Co. from 2020 to 2024, and Board Member at Triplet Therapeutics, Inc. Education includes an MBA from Northeastern University in 2014, undergraduate degree from Princeton University in 1988, graduate and doctorate degrees from Sidney Kimmel Medical College in 1995, and a doctorate from Thomas Jefferson University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-12 | 167,599 ( 0.1% ) | 4 M $ | 2026-07-30 |
Douglas Kerr active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-09-02 |
Exceptional Ventures LLP
 Exceptional Ventures LLP Investment ManagersFinance Exceptional Ventures invests in companies located across the globe primarily in the United Kingdom, in the United States and Europe. The firm focuses on healthtech, foodtech, and financial health sectors. It participates in pre-seed, seed, and early stage capital requirements. | Consultant / Advisor | 2022-02-28 |
Cure Sma | Director/Board Member | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Former positions of Douglas Kerr
| Companies | Position | End |
|---|---|---|
| GENERATION BIO CO. | Chief Tech/Sci/R&D Officer | 2024-01-27 |
Faze Medicines, Inc. /MA)
 Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Provides business services | Director/Board Member | 2023-03-02 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Consultant / Advisor | 2021-11-29 |
| SHIRE | Corporate Officer/Principal | - |
| BIOGEN INC. | Director/Board Member | 2015-09-30 |
Training of Douglas Kerr
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Cure Sma | |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Provides business services | Commercial Services |
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Operates as an engineered cell therapy company which develops regenerative medicines for intractable diseases | Commercial Services |
AAVantgarde Bio Srl
 AAVantgarde Bio Srl BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Exceptional Ventures LLP
Exceptional Ventures LLP Investment ManagersFinance Exceptional Ventures invests in companies located across the globe primarily in the United Kingdom, in the United States and Europe. The firm focuses on healthtech, foodtech, and financial health sectors. It participates in pre-seed, seed, and early stage capital requirements. | Finance |
GenrAb, Inc.
 GenrAb, Inc. BiotechnologyHealth Technology Develops neuroprotective and neurotherapeutic human antibodies | Health Technology |
- Stock Market
- Insiders
- Douglas Kerr
